Get the Stockscreener App
1.25
0.00%
0.00
After Hours:
1.28
0.03
+2.40%
Neurosense Therapeutics Ltd stock is traded at $1.25, with a volume of 132.82K.
It is up +0.00% in the last 24 hours and up +17.92% over the past month.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
See More
Previous Close:
$1.25
Open:
$1.29
24h Volume:
132.82K
Relative Volume:
0.22
Market Cap:
$31.30M
Revenue:
-
Net Income/Loss:
$-13.76M
P/E Ratio:
-1.3441
EPS:
-0.93
Net Cash Flow:
-
1W Performance:
-0.79%
1M Performance:
+17.92%
6M Performance:
+34.42%
1Y Performance:
-1.57%
1-Day Range:
$1.20
$1.30
1-Week Range:
$1.15
$1.30
52-Week Range:
$0.80
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Name
Neurosense Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare NRSN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.25 | 31.30M | 0 | -13.76M | 0 | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurosense Therapeutics Ltd Stock (NRSN) Latest News
Will NeuroSense Therapeutics Ltd. Equity Warrant bounce back from current supportJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-09-30 20:29:52 - newser.com
Is NeuroSense Therapeutics Ltd. (H1Z) stock undervalued after correctionEarnings Miss & Real-Time Volume Trigger Notifications - newser.com
Why NeuroSense Therapeutics Ltd. stock is rated strong buyWeekly Risk Report & AI Powered Market Entry Strategies - newser.com
Why NeuroSense Therapeutics Ltd. (H1Z) stock attracts wealthy investorsJuly 2025 Market Mood & Accurate Intraday Trade Tips - newser.com
Will NeuroSense Therapeutics Ltd. stock continue dividend increases2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Heatmap analysis for NeuroSense Therapeutics Ltd. Equity Warrant and competitorsJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Will NeuroSense Therapeutics Ltd. stock return to pre crisis levelsJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com
NeuroSense Therapeutics Ltd. stock momentum explainedQuarterly Earnings Summary & Low Risk Entry Point Guides - newser.com
Is NeuroSense Therapeutics Ltd. Equity Warrant stock undervalued vs historical averagesWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock maintain dividend yieldQuarterly Portfolio Review & Precise Trade Entry Recommendations - newser.com
How sentiment analysis helps forecast NeuroSense Therapeutics Ltd. Equity WarrantTrade Performance Summary & Consistent Income Trade Ideas - newser.com
Can NeuroSense Therapeutics Ltd. Equity Warrant rally from current levelsWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
What drives NeuroSense Therapeutics Ltd stock priceEx-Dividend Date Alerts & Fast Growing Investment Ideas - earlytimes.in
Leading vs lagging indicators on NeuroSense Therapeutics Ltd. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com
Published on: 2025-09-29 10:10:33 - newser.com
Why NeuroSense Therapeutics Ltd. (H1Z) stock is a must watch ticker2025 Big Picture & Long-Term Growth Stock Strategies - newser.com
Will NeuroSense Therapeutics Ltd. (H1Z) stock draw ESG focused fundsExit Point & Fast Gaining Stock Strategy Reports - newser.com
Published on: 2025-09-29 04:29:55 - newser.com
Why hedge funds are buying NeuroSense Therapeutics Ltd. Equity Warrant stock2025 Geopolitical Influence & Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-09-29 00:44:31 - newser.com
Is NeuroSense Therapeutics Ltd Equity Warrant a good long term investmentDay Trading Setups & Free Discover Fast Growing Stocks - earlytimes.in
What drives NeuroSense Therapeutics Ltd H1Z stock priceFibonacci Retracement Levels & Free Expert Stock Watchlists - earlytimes.in
Will a bounce in NeuroSense Therapeutics Ltd. offer an exitExit Point & AI Powered Buy/Sell Recommendations - newser.com
Volume spikes in NeuroSense Therapeutics Ltd. stock – what they mean2025 Price Targets & Risk Controlled Daily Plans - newser.com
Neurosense Therapeutics Ltd Stock (NRSN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):